Safety, PK and Efficacy of PCS12852 on Gastric Emptying Rate in Patients With Moderate to Severe Gastroparesis
Trial details
- Registry ID
- NCT05270460
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as 5HT4 receptor agonist
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Safety, PK and Efficacy of PCS12852 on Gastric Emptying Rate in Patients With Moderate to Severe GastroparesisNCT05270460 | Processa Pharmaceuticals | Phase 2 | Completed | 2022-09-29Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |